Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 20;385(6715):1278-1279.
doi: 10.1126/science.adq5252. Epub 2024 Sep 19.

The prion principle and Alzheimer's disease

Affiliations

The prion principle and Alzheimer's disease

Lary C Walker et al. Science. .

Abstract

Similarities to molecular mechanisms underlying prion diseases may help to refine Alzheimer's disease therapies.

PubMed Disclaimer

Figures

Figure.
Figure.. The prion principle.
A normally generated protein folds into an alternative molecular structure that self-propagates by structurally corrupting cognate protein molecules. The misfolded molecules self-assemble into multimers that then proliferate by fragmentation, propagation, and spread, causing cytopathologic sequelae in neurons (orange) and glial cells (purple and blue) that contribute to the resulting disease. Proteins can fold into alternative strains, and depending on the protein, propagation may occur extracellularly and/or intracellularly. In many (but not all) cases, the corrupted proteins amass into lesions known as amyloids.

References

    1. Prusiner SB, Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47, 601–623 (2013). - PMC - PubMed
    1. Jia J et al. , Biomarker Changes during 20 Years Preceding Alzheimer’s Disease. N Engl J Med 390, 712–722 (2024). - PubMed
    1. Li Y et al. , Timing of Biomarker Changes in Sporadic Alzheimer’s Disease in Estimated Years from Symptom Onset. Ann Neurol 95, 951–965 (2024). - PMC - PubMed
    1. Jucker M, Walker LC, Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45–51 (2013). - PMC - PubMed
    1. Goedert M, Tau proteinopathies and the prion concept. Prog Mol Biol Transl Sci 175, 239–259 (2020). - PubMed

Publication types